Found 167 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy PHASE2 Chemotherapy induced nausea and vomiting (CINV) is a major adverse effect o...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting PHASE4 This study is being done to determine the efficacies of two preventative dr...
Show More Location
The Ohio State University Wexner Medical Center
Learn More & Join Trial
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting PHASE3 The goal of this clinical trial is to learn if medroxyprogesterone acetate ...
Show More Location
The First Affiliated Hospital of Xinxiang Medical University
Learn More & Join Trial
Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) PHASE3 The purpose of this study is to determine the efficacy and tolerability of ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148) PHASE1 This two part study will determine the appropriate dosing regimen of aprepi...
Show More Location
Call for Information (Investigational Site 0003)
Learn More & Join Trial
Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting NA Recent evidence suggests multiple drug therapy is superior to single agents...
Show More Location
Hahnemann University Hospital
Learn More & Join Trial
Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients NA Children aged 2-12 years scheduled to receive moderately or highly emetogen...
Show More Location
Shanghai Children's Medical Center
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation PHASE4 The purpose of this study is to evaluate the efficacy and safety of additio...
Show More Location
Multiple Locations
Learn More & Join Trial
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy PHASE4 Bariatric surgery remains the most effective therapy for obesity. Postopera...
Show More Location
Stony Brook University Hospital
Learn More & Join Trial